NephroDI Receives Sound Bioventures Investment For NDI-5001 Development
20 Jun 2024 //
GLOBENEWSWIRE
NephroDI Therapeutics and MSRD partner to develop therapy for NDI
23 Jun 2023 //
PHARMACEUTICAL TECHNOLOGY
NephroDI Therapeutics Enters Agreement to Develop a First-in-Class
22 Jun 2023 //
BUSINESSWIRE